Trial · NCT06235086
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Changes in glycosylated hemoglobin (HbA1c) from baseline at 28 weeks of treatment | Baseline through Week28 | |
| Secondary | Changes in HbA1c from baseline at 52 weeks of treatment | Baseline through Week52 | |
| Secondary | The percentage of HbA1c≤6.5% and the percentage of HbA1c≤7% at week 28 and 52 | Week28 and 52 | |
| Secondary | Change in fasting plasma glucose (FPG) from baseline at week 28 and 52 | Baseline through Week28 and 52 | |
| Secondary | Change in weight from baseline at week 28 and 52 | Baseline through Week28 and 52 | |
| Secondary | Change in 2h-postprandial plasma glucose (2h-PPG) from baseline at week 28 and 52 | Baseline through Week28 and 52 | |
| Secondary | Mean 7 point blood glucose curve from baseline at week 28 and 52. Change in mean postprandial blood glucose increment from baseline at week 28 and 52. | Baseline through Week28 and 52 | |
| Secondary | Change in blood lipids (triglycerides, total cholesterol, high-density lipoprotein cholesterol, and low-density lipoprotein cholesterol) from baseline at week 28 and 52. | Baseline through Week28 and 52 | |
| Secondary | Proportion of subjects receiving remedial therapy at week 28 and 52 | Week28 and 52 | |
| Secondary | Incidence of adverse events | Week-2 through 52 | |
| Secondary | Blood concentrations of TG103 | Week 0, 4, 8,16, 28, 36, 44, 52 and 55 | |
| Secondary | The occurrence of TG103 anti-drug antibodies (ADA) and neutralizing antibody (NAb). | Week 0, 4, 8,16, 28, 36, 44, 52 and 55 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06235086/registered